99 related articles for article (PubMed ID: 16879394)
61. Substance P--a potent risk factor in childhood lymphoblastic leukaemia.
Nowicki M; Miśkowiak B
Leukemia; 2003 Jun; 17(6):1096-9. PubMed ID: 12764374
[TBL] [Abstract][Full Text] [Related]
62. [Protein and mRNA expression of CTGF, CYR61, VEGF-C and VEGFR-2 in bone marrow of leukemia patients and its correlation with clinical features].
He QT; Bai XQ; Liu XW; Xu N; Lu Y; Zhang DX; Li J; Yun Y; Li ZQ; Han HY; Han XM; Ma HJ; Zhao ZY; Jia GR; Li Z; Yuan XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):653-9. PubMed ID: 24989271
[TBL] [Abstract][Full Text] [Related]
63. Vascular endothelial growth factor-C and its receptor type-3 expressed in acute lymphocytic leukemia cases with t(1;19).
Shirasaki R; Tashiro H; Oka Y; Sugao T; Yamamoto T; Yoshimi M; Akiyama N; Kawasugi K; Shirafuji N
Int J Hematol; 2011 Aug; 94(2):203-208. PubMed ID: 21732038
[TBL] [Abstract][Full Text] [Related]
64. Children with acute lymphoblastic leukaemia have high plasma levels of total homocysteine at time of diagnosis.
Ruud E; Holmstrøm H; Brosstad F; Wesenberg F
Scand J Clin Lab Invest; 2006; 66(1):67-78. PubMed ID: 16464788
[TBL] [Abstract][Full Text] [Related]
65. Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemia.
Lyu CJ; Rha SY; Won SC
Yonsei Med J; 2007 Apr; 48(2):171-5. PubMed ID: 17461513
[TBL] [Abstract][Full Text] [Related]
66. A morphometric approach for the evaluation of angiogenesis in acute lymphoblastic leukemia of childhood.
Kalmanti L; Dampaki K; Dimitriou H; Stiakaki E; Chaniotis V; Stathopoulos E
Leuk Res; 2005 Jun; 29(6):673-7. PubMed ID: 15863208
[TBL] [Abstract][Full Text] [Related]
67. Relationship between serum copper and bone marrow blasts in acute leukaemia.
Legutko L
Haematologia (Budap); 1977; 11(3-4):297-300. PubMed ID: 283968
[TBL] [Abstract][Full Text] [Related]
68. Nephrotic syndrome unfavorable course correlates with downregulation of podocyte vascular endothelial growth factor receptor (VEGFR)-2.
Ostalska-Nowicka D; Malinska A; Zabel M; Witkiewicz W; Nowicki M
Folia Histochem Cytobiol; 2011; 49(3):472-8. PubMed ID: 22038228
[TBL] [Abstract][Full Text] [Related]
69. Detection of substance P and its mRNA in human blast cells in childhood lymphoblastic leukaemia using immunocytochemistry and in situ hybridisation.
Nowicki M; Miśkowiak B; Ostalska-Nowicka D
Folia Histochem Cytobiol; 2003; 41(1):33-6. PubMed ID: 12705477
[TBL] [Abstract][Full Text] [Related]
70. Correlation between early treatment failure and Ki67 antigen expression in blast cells of children with acute lymphoblastic leukaemia before commencing treatment. A retrospective study.
Nowicki M; Miśkowiak B; Kaczmarek-Kanold M
Oncology; 2002; 62(1):55-9. PubMed ID: 11810044
[TBL] [Abstract][Full Text] [Related]
71. Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance.
Pulè MA; Gullmann C; Dennis D; McMahon C; Jeffers M; Smith OP
Br J Haematol; 2002 Sep; 118(4):991-8. PubMed ID: 12199777
[TBL] [Abstract][Full Text] [Related]
72. Effect of heat shock protein-90 (HSP90) and vascular endothelial growth factor (VEGF) on survival in acute lymphoblastic leukemia: an immunohistochemical study.
Hacıhanefioglu A; Gonullu E; Mehtap O; Keski H; Yavuz M; Ercin C
Med Oncol; 2011 Sep; 28(3):846-51. PubMed ID: 20422320
[TBL] [Abstract][Full Text] [Related]
73. Changes in the Concentrations of Proangiogenic Cytokines in Human Brain Glioma and Acute Lymphoblastic Leukemia.
Oldak L; Zielinska Z; Milewska P; Chludzinska-Kasperuk S; Latoch E; Konończuk K; Krawczuk-Rybak M; Starosz A; Grubczak K; Reszeć J; Gorodkiewicz E
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473833
[TBL] [Abstract][Full Text] [Related]
74. Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia.
Faderl S; Do KA; Johnson MM; Keating M; O'brien S; Jilani I; Ferrajoli A; Ravandi-Kashani F; Aguilar C; Dey A; Thomas DA; Giles FJ; Kantarjian HM; Albitar M
Blood; 2005 Dec; 106(13):4303-7. PubMed ID: 16123221
[TBL] [Abstract][Full Text] [Related]
75. Plasma CD105, TGFbeta-1, TGFbeta-3 and the ligand/receptor complexes in children with acute lymphoblastic leukaemia.
Al-Mowallad A; Carr T; Al-Qouzi A; Li C; Byers R; Kumar S
Anticancer Res; 2006; 26(1B):543-7. PubMed ID: 16739317
[TBL] [Abstract][Full Text] [Related]
76. Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Newly Diagnosed Paediatric Acute Lymphoblastic Leukemia.
Meena R; Nangia A; Sharma S; Chandra J
Indian J Hematol Blood Transfus; 2021 Oct; 37(4):586-592. PubMed ID: 34744342
[TBL] [Abstract][Full Text] [Related]
77. Proliferation and apoptosis does not affect presenting white cell count in childhood ALL.
Pyesmany AF; Ball LM; Yhap M; Henry M; Laybolt K; Riddell DC; van Velzen D
Adv Exp Med Biol; 1999; 457():305-12. PubMed ID: 10500806
[TBL] [Abstract][Full Text] [Related]
78. Quantification of vascular endothelial growth factor-C.
Al-Mowallad AF; Li C; Wilson P; Duff S; Costello B; Al Qozi A; Kumar S
J Immunol Methods; 2004 Jun; 289(1-2):239-40. PubMed ID: 15251428
[No Abstract] [Full Text] [Related]
79. Florid bone marrow haematogones in a child following treatment for acute lymphoblastic leukaemia.
Das PK; Malkin D; Ye CC
Br J Haematol; 2006 Feb; 132(3):254. PubMed ID: 16409289
[No Abstract] [Full Text] [Related]
80. Vascular endothelial growth factor levels in childhood acute lymphoblastic and myeloblastic leukemia.
Leblebisatan G; Antmen B; Saşmaz I; Kilinç Y
Indian J Hematol Blood Transfus; 2012 Mar; 28(1):24-8. PubMed ID: 23449155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
